Guidance for Industry: Q3C Impurities: Residual Solvents
...the drug product and the calculated maximum content of residual acetonitrile are given in.....test for solvents that are used or produced in the manufacture or purification of drug substances, excipients, or drug.....5) Manufacturers of pharmaceutical products need certain information about the content of..
http://www.fda.gov/cber/gdlns/q3cresolvent.pdf (score=100)
þÿ
...the drug product and the calculated maximum content of residual acetonitrile are given in.....test for solvents that are used or produced in the manufacture or purification of drug substances, excipients, or drug.....5) Manufacturers of pharmaceutical products need certain information about the content of..
http://www.fda.gov/cder/guidance/Q3Cfnl.pdf (score=58)
BA/BE studies for Nasal Aerosols and Nasal Sprays for Local Ac
...active ingredient/active moiety is intended for local action, regardless of drug or drug.....test such as dose content uniformity has acceptance criteria based on repeated.....quality perspective, the critical issues are release of drug substance from drug product..
http://www.fda.gov/cder/guidance/2070dft.pdf (score=58)
MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....distribution, crystallinity, dose content uniformity, microbial content, and stability.....The guidance sets forth information that should be provided to ensure continuing drug..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=19)
FR Doc 04-2536
...Submit written requests for single copies of the draft guidance to the Division of Drug.....The draft guidance provides information on submitting the content of labeling in.....Paperwork Reduction Act of 1995 The information requested for human drug and biological..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04-2536.htm (score=19)
...The Need for Revised Prescription Drug Labeling Although the format and content requirements for prescription drug labeling in.....The revised content and format requirements in the proposed rule would not apply to drug.....This proposal would also amend prescription drug labeling requirements for older drugs to..
http://www.fda.gov/OHRMS/DOCKETS/98fr/122200a.htm (score=19)
Content and Format of the Adverse Reactions Section of Labeling for Human...
...The ADVERSE REACTIONS section of the labeling should contain drug safety information that.....Content and Format of the Adverse Reactions Section of Labeling for Human Prescription.....The overview is intended to briefly highlight the information in a drug_s adverse reaction..
http://www.fda.gov/cder/guidance/1888dft.htm (score=19)
Guidance for Industry: Industry-Supported Scientific and Educational Activities
...of a drug or device while it is held for sale after.. umbrella of an overall regulatory.....that the company and provider agree to, the ultimate content of presentations is.....single drug products, had misleading.. increased the greatest in absolute terms..
http://www.fda.gov/cber/gdlns/sciedu.pdf (score=19)
Draft Guidance for Industry Content and Format of the Adverse Reactions...
...use of a drug, that may occur as part of the pharmacological action of the drug or may be.....Although this guidance seeks to bring greater consistency to the content and format of the.....contain drug safety information that is important to prescribing decisions and should..
http://www.fda.gov/cber/gdlns/cfadvers.pdf (score=19)
Guidance for Industry - Content and Format of the Adverse Reactions Section...
...The ADVERSE REACTIONS section of the labeling should contain drug safety information that.....Content and Format of the Adverse Reactions Section of Labeling for Human Prescription.....The overview is intended to briefly highlight the information in a drug's adverse reaction..
http://www.fda.gov/cber/gdlns/cfadvers.htm (score=19)
/a//content.19839
...45 am] Research, Food and Drug Administration, persons of decisions on matters considered.....Food and Drug Administration, Implementing Section 120 of the Food and.. the Modernization.....drug product, the content of a guidance.. PUBLICATION DATE: 11-2-98.. FOR FURTHER INFORMATION CONTACT..
http://www.fda.gov/cber/genadmin/120fdama.pdf (score=19)
/a//content.31904
http://www.fda.gov/cder/ogd/rld/17854s39.pdf (score=19)
FR Doc 04-15660
...Guidance for Industry, FDA Staff and Drug Administration, 9200 Corporate Third Parties.....Content of Submissions to the Food Do and Drug Administration in Support of.....Content of Premarket Submissions for Center for Do Biologics Evaluation and Research..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04-15660.htm (score=18)
þÿ
...Submitting Supporting Documentation in Drug Applications for the Manufacture of Drug.....Format and Content of the Human Pharmacokinetics and Bioavailability Section of an.....Prescription Drug Marketing Act Regulations for Donation of Prescription Drug Samples to..
http://www.fda.gov/cder/guidance/guidlist.pdf (score=18)
/a//content.29116
http://www.fda.gov/ohrms/dockets/dailys/02/Jun02/062802/02p-0297-ack0001-vol1.pdf (score=18)
Guidance for Industry: The Content and Format for Pediatric Use Supplements
...Under the rule, FDA may approve a drug for pediatric use based on..adequate and well.....CONTENT AND FORMAT..The following information should be included in the supplement in the.....the course of the disease and effects of the drug are sufficiently similar in..adults and..
http://www.fda.gov/cber/gdlns/GDEPED.pdf (score=18)
The New Food Label
...Under regulations from the Food and Drug Administration of the Department of Health and.....FDA requires nutrition information for foods about which health or nutrient-content claims.....Also, these foods will lose their exemption if their labels carry a nutrient content or..
http://www.fda.gov/opacom/backgrounders/foodlabel/newlabel.html (score=18)
Guidance for Industry: Q&A Content and Format of INDs for Phase 1 Studies of...
...This guidance represents the Food and Drug Administration=s current thinking on this topic.....Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-Characterized.....the Food and Drug Administration. There has been some confusion over when the 120-day..
http://www.fda.gov/cber/gdlns/qaind1.pdf (score=18)
...0 Guidance for the Preparation and December 4, 1987 Do Do Content of Applications to the Food and Drug Administration for.....Drug Advertising and Promotional Labeling DDMAC 2 Dissemination of Reprints of Certain.....the decision making tree Suggested Content for Original IDE February 27, 1996 Do Do..
http://www.fda.gov/cber/gdlns/guidelst.txt (score=18)
/a//content.1058
http://www.fda.gov/cder/ogd/rld/18998s57.pdf (score=18)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer